Valneva SE (INRLF)
3.29
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Valneva Shareholders Equity (Quarterly) : 92.75M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.75M |
| March 31, 2026 | 88.37M |
| December 31, 2025 | 124.69M |
| September 30, 2025 | 176.81M |
| June 30, 2025 | 218.84M |
| March 31, 2025 | 189.31M |
| December 31, 2024 | 187.69M |
| September 30, 2024 | 242.71M |
| June 30, 2024 | 178.21M |
| March 31, 2024 | 204.37M |
| December 31, 2023 | 141.67M |
| September 30, 2023 | 166.78M |
| June 30, 2023 | 208.06M |
| March 31, 2023 | 222.49M |
| December 31, 2022 | 234.58M |
| September 30, 2022 | 161.63M |
| June 30, 2022 | 97.49M |
| March 31, 2022 | 165.12M |
| December 31, 2021 | 193.99M |
| September 30, 2021 | |
| June 30, 2021 | 91.40M |
| March 31, 2021 | 61.53M |
| December 31, 2020 | 94.73M |
| September 30, 2020 | 89.98M |
| June 30, 2020 | 124.74M |
| Date | Value |
|---|---|
| March 31, 2020 | 146.11M |
| December 31, 2019 | 151.71M |
| September 30, 2019 | 143.50M |
| June 30, 2019 | 150.01M |
| March 31, 2019 | 156.29M |
| December 31, 2018 | 163.68M |
| September 30, 2018 | 104.22M |
| June 30, 2018 | 107.35M |
| March 31, 2018 | 116.50M |
| December 31, 2017 | 111.28M |
| September 30, 2017 | 113.74M |
| June 30, 2017 | 111.93M |
| March 31, 2017 | 106.38M |
| December 31, 2016 | 105.53M |
| September 30, 2016 | 109.66M |
| June 30, 2016 | 115.84M |
| March 31, 2016 | 159.27M |
| December 31, 2015 | 156.79M |
| September 30, 2015 | 162.09M |
| June 30, 2015 | 168.21M |
| March 31, 2015 | 170.16M |
| December 31, 2014 | 150.58M |
| September 30, 2014 | 172.95M |
| June 30, 2014 | 192.93M |
| March 31, 2014 | 189.13M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | -- |
| Cellectis SA | 41.07M |
| Genfit SA | -- |
| Innate Pharma SA | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 443.92M |
| Total Liabilities (Quarterly) | 351.17M |
| Debt to Equity Ratio | 2.592 |
| Current Ratio | 2.157 |
| Net Debt Paydown Yield | -0.49% |